Projects and Grants per year
Personal profile
Research Interests
- Multiple Myeloma
- Leukemia
- Lymphoma
- Hematologic Malignancies
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Post Doctoral Fellow, University Of Kentucky
2006
Residency, Indiana University
2003
Doctor of Medicine, University Of Kentucky
2000
Bachelor of Arts, Transylvania University
1996
Fingerprint
Dive into the research topics where Gregory Monohan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
23-MYEL-21-RG: An Open-Label, Randomized, Phase 3 Study of Linvoseltamab (REGN5458; Anti-BCMA x Anti-CD3 Bispecific Antibody) Vs. The Combination of Elotuzumab, Pomalidomide, and Dexamethasone (EPd), in Patients with Relapsed/Refractory Mulitple Myeloma (
Monohan, G. (PI)
6/27/24 → 6/27/26
Project: Research project
-
A Phase 3 Randomized Study Comparing Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Ciltacabtagene Autoleucel, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA Versus Bortezomib, Lenalidomide, and D
Monohan, G. (PI)
Janssen Research and Development LLC
3/15/22 → 1/29/24
Project: Research project
-
Unveiling the Genetic and Clinical Differences of Acute Myeloid Leukemia (AML) in Obese Patients
Yalniz, F. F., Johnson, A., Alnimer, Y., Chahine, Z., Morris, T., Yadav, R., Taj, H., Iragavarapu, C., Munker, R., Monohan, G., Wai, S., Zhang, S., Nozad, S. & Qasrawi, A., Feb 2025, In: European Journal of Haematology. 114, 2, p. 365-372 8 p.Research output: Contribution to journal › Article › peer-review
-
Performance status, comorbidities, and cycles of methotrexate exert the greatest influence on outcomes of primary and secondary CNS lymphomas: the Lexington experience
Curry, L. D., Munker, R., Li, N., Yan, D., Pryor, P., Nozad, S., Keller, P., Monohan, G. P., Iragavarapu, C. & Krem, M. M., Jan 2023, In: Annals of Hematology. 102, 1, p. 141-154 14 p.Research output: Contribution to journal › Article › peer-review
9 Scopus citations -
Age Adjusted Comorbidity Risk Index Does Not Predict Outcomes in an Autologous Hematopoietic Stem Cell Transplant Population
Barth, D., Singleton, M., Monohan, G., McClune, B. & Adams, V., Feb 2022, In: Cell Transplantation. 31Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
AML-434 Retrospective Review of Outcomes in Newly Diagnosed Leukemia Patients Aged 65 and Older When Admitted to the Hospital: A Single Center Experience
Canter, C., Hildebrandt, G., Iragavarapu, C., Munker, R., Qasrawi, A., Ramlal, R. & Monohan, G., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S250Research output: Contribution to journal › Article › peer-review
-
Treatment-Associated Acute Lymphoblastic Leukemia Following Autologous Hematopoietic Stem Cell Transplant and Lenalidomide Maintenance in Patients With Multiple Myeloma
Crosby, J., Erzuah, T., Haider, M., Smith, F., Ganti, S., Monohan, G. & Elsouiedi, R., 2022, In: Journal of Investigative Medicine High Impact Case Reports. 10Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations